Users Discontinuing Slimming Medications Put On Weight at a Quadrupled Rate Than People Using Diet and Exercise

Fresh analysis indicates that people who discontinue popular GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who end traditional lifestyle programs.

Research printed in a leading health publication points out that while obese people can lose a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month once they quit.

"Users buying these medications must be cognizant of the risk of quick weight regain when the treatment is stopped," warns researcher Dr. Susan Jebb.

Such speed of recovery implies a return to original mass in about a year and a half.

Comparing Therapies

The study, which looked at 37 of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.

The team point out that people who lose weight through dieting typically see a slower weight regain—perhaps 100 grams monthly—after stopping.

Understanding the Quick Regain

Experts propose the mode of action of the injections accounts for the accelerated weight return.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement means appetite is uncontrolled, making binge eating much more probable."

A Chronic Disease?

The NHS recommend the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.

A number of clinicians argue that, given the significant potential of weight regain, the therapy is often life-long.

This opinion is supported by pharmaceutical companies, who state that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like diabetes.

Patient Experiences

People who have come off the jabs explain a intense return of cravings.

"I experienced a switch flipping and you're instantly starving," said one woman.

The struggle is compounded if individuals have not adopted permanent dietary or behavioural modifications during therapy.

Widespread Interest

Recent estimates indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire remaining high.

• Adoption is more common among females than males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion access the medications through private healthcare rather than public health services.

Ultimately, clinicians emphasize that while the jabs are potent tools for shedding pounds, they are not a standalone cure and maintained weight loss hinges on ongoing lifestyle management.